Patents by Inventor Thomas Magauer

Thomas Magauer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Trioxacarcins and uses thereof
    Patent number: 9611287
    Abstract: The present invention relates to trioxacarcin compounds of the formula: or pharmaceutically acceptable forms thereof; wherein R1, R2, R3, R4, R5, R6, R7, R8, and R9 are as defined herein. The present invention also provides processes for preparing such compounds and intermediates thereto; pharmaceutical compositions comprising such compounds; and methods of use and treatment.
    Type: Grant
    Filed: July 28, 2015
    Date of Patent: April 4, 2017
    Assignee: President and Fellows of Harvard College
    Inventors: Andrew G. Myers, Nicholas E. Hill, Jakub Svenda, Robert T. Yu, Daniel J. Smaltz, Thomas Magauer
  • TRIOXACARCINS AND USES THEREOF
    Publication number: 20160355537
    Abstract: The present invention relates to trioxacarcin compounds of the formula: or pharmaceutically acceptable forms thereof; wherein R1, R2, R3, R4, R5, R6, R7, R8, and R9 are as defined herein. The present invention also provides processes for preparing such compounds and intermediates thereto; pharmaceutical compositions comprising such compounds; and methods of use and treatment.
    Type: Application
    Filed: July 28, 2015
    Publication date: December 8, 2016
    Applicant: President and Fellows of Harvard College
    Inventors: Andrew G. Myers, Nicholas E. Hill, Jakub Svenda, Robert T. Yu, Daniel J. Smaltz, Thomas Magauer
  • Trioxacarcins and uses thereof
    Patent number: 9102697
    Abstract: The present invention relates to trioxacarcin compounds of the formula: (I) or pharmaceutically acceptable forms thereof; wherein R1, R2, R3, R4, R5, R6, R7, R8, and R9 are as defined herein. The present invention also provides processes for preparing such compounds and intermediates thereto; pharmaceutical compositions comprising such compounds; and methods of use and treatment.
    Type: Grant
    Filed: March 22, 2011
    Date of Patent: August 11, 2015
    Assignee: President and Fellows of Harvard College
    Inventors: Andrew G. Myers, Nicholas E. Hill, Jakub Svenda, Robert T. Yu, Daniel J. Smaltz, Thomas Magauer
  • TRIOXACARCINS AND USES THEREOF
    Publication number: 20130150314
    Abstract: The present invention relates to trioxacarcin compounds of the formula: (I) or pharmaceutically acceptable forms thereof; wherein R1, R2, R3, R4, R5, R6, R7, R8, and R9 are as defined herein. The present invention also provides processes for preparing such compounds and intermediates thereto; pharmaceutical compositions comprising such compounds; and methods of use and treatment.
    Type: Application
    Filed: March 22, 2011
    Publication date: June 13, 2013
    Applicant: President and Fellows of Harvard College
    Inventors: Andrew G. Myers, Nicholas E. Hill, Jakub Svenda, Robert T. Yu, Daniel J. Smaltz, Thomas Magauer